Frederick L. Locke, MD is a medical oncologist and translational investigator dedicated to discovering and implementing ways to use the immune system against lymphoid malignancies. He is the Co-Leader of the Immuno-Oncology Program at Moffitt Cancer Center, where he also serves as Vice-Chair and an Associate member in the Department of Blood and Marrow Transplant and Cellular Immunotherapy. Dr. Locke oversaw the creation, and leads, Moffitt’s Immune Cell Therapy (ICE-T) program. This cross departmental effort provides specialized care of high-risk immunotherapy and cellular therapy patients, regardless of tumor type. Dr. Locke is a first or senior author on numerous high impact publications, including articles in the New England Journal of Medicine, Lancet Oncology, Journal of Clinical Oncology, JAMA Oncology, and Blood.